Details
Category: Volume 07 Issue 02 February 2019
Hits: 938

Title: Ten years follow up study in Locally advanced Cancer Cervix treated with Hyperfractionated Radiotherapy, Concurrent Chemotherapy and HDR Brachy Therapy

Authors: Dr B. Antoinette Mary Nithiya, Dr A. Anand Praveen Kumar

 DOI: https://dx.doi.org/10.18535/jmscr/v7i2.160

Abstract

Aim: Cancer cervix is common malignancy among women globally spanning various continents in the world. The incidence of invasive cervical carcinoma has dropped dramatically due to effective screening techniques. But in India Women present at a locally advanced stage due to lack of awareness and ignorance. The patients are treated and are lost follow up mostly. This study was a continued effort to follow up a group of patient treated in March 2006 to September 2006. Their course of disease and toxicities and their present conditions were analyzed at the end of 10 years.

Patients and Methods: The 24 patients with locally advanced cancer underwent hyper fractionated radiotherapy and concurrent chemotherapy and brachytherapy during the period  March 2006 to September 2006.  One patient opted out of study at the end of treatment. The rest 23 patients were followed up and condition analyzed at the end of 10 years. Overall survival disease free survival, toxicities and recurrence patterns. Among 13 patients available were analyzed. The various assessments done were detailed history, symptoms clinical examination, USG abdomen, Ct abdomen and pelvis, cystoscopy and Proctoscopy.

Results: Of the 23 patients 7 were lost follow up, 3 expired. Overall survival 13 patients disease free for survival 10 patients, 3 patients had local recurrence and undergone Wertheim’s hysterectomy, 1 patient had skeletal metastasis and undergone RT to spine.

Conclusion: The improvement in the treatment response obtained soon after treatment in our study compared with conventional protocol was sustained even after 10 years which showed a definite improvement in overall survival and disease free survival with acceptable late toxicities. We recommend a randomized study with large number of patients to prove that we achieve in our study are significant.

Keywords:  Hyper fractionated Radiotherapy, Concurrent chemotherapy, brachytherapy, cancer cervix, cistplatin 

References

  1. Blake et al  - Combined  radiotherapy  and  chemotherapy  for advanced carcinoma   of the cervix. Clinical radiology 37(5):465- 469 Sep 1986.
  2. Potish et al - Effect of Cisplatin on tolerance to radiation therapy in advanced  cervical    American journal  of  clinical radiology. Vol 9:387-391, 1986.
  3. Twiggs et al - Concurrent weekly Cisplatin and radiotherapy in advanced cervical Cancer. Gynecol oncology 24: 143-148, 1986. 61:416-422,
  4. Fields et al - Mature results of a phase- II study on concomitant Cisplatin& pelvic  radiotherapy  in  locally  advanced  cervical cancer. Gynec oncology 1996.
  5. Runowicz et al - Concurrent Cisplatin and radiotherapy in locally advanced cancer cervix. Gynec oncology -34:395-401, 1989
  6. Souhami et al - Weekly Cisplatin and external beam radiation and HDR brachytherapy in locally advanced cancer cervix. Int J Radiat Oncol Biol Phys.
  7. Whitney et al-GOG 85 report. Journal of clinical oncology. Vol- 17:13391345,   
  8. G. Rose et al - GOG 120 report. NEJM 340(15)1144-1153, April 1999.
  9. Henry .M. Keys et a1 - GOG 123 report. NEJM 340( 15) 1154- 1161, April
  10. Morris et a1 RTOG- 90-01 report. NEJM 340(15)1137- 1143, April 1999.
  11. Peters et a1 SWOG-87-97 report- Gynec oncology 72: 443-450, 1999.
  12. Ritsukokomaki M.D, Thomas F.Pajak,etal Victor A Marcial Twice daily fractionation of external irradiation with brachytherapy in Bulky carcinoma of cervix RTOG 88-05 Cancer 1994 : 73 : 2619- 25.
  13. Alison R Calkins. M.D et al hyper fractionated Radiation Therapy plus chemotherapy  in  locally  advanced  cervical  cancer Gynecologic oncology 5:3:349-355 1999.
  14. W. Gregsby .J.D.LU: David Mutch ; Robert Y Kim patricia J Eifel. et. al Twice daily  fractionation  of  external  irradiation  with brachytherapy and chemotherapy in carcinoma of cervix with positive para – aortic lymph nodes Gynecology cancer working group- IntJou.Rad Oncology, Biology and physics-51(3) 58-59 , 2001.
  15. Baskaran et al Toxicities and tolerance of the Cancer Cervix patients Asian journal of Pharmaceutical and Clinical Research.Vol.4 Issue 1, 2011.

Corresponding Author

Dr B. Antoinette Mary Nithiya

Stanley Medical College

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.